Elsevier

Methods in Enzymology

Volume 234, 1994, Pages 482-492
Methods in Enzymology

[48] N-acetylcysteine

https://doi.org/10.1016/0076-6879(94)34119-2Get rights and content

Publisher Summary

N-Acetylcysteine (NAC) is a thiol-containing compound that has been used in clinical practice for several years. Historically, NAC was introduced for the treatment of congestive and obstructive lung diseases; primarily those associated with hypersecretion of mucus, for example, chronic bronchitis and cystic fibrosis. NAC has also been used as the drug of choice in the treatment of paracetamol intoxication. Currently, NAC and its applications include use in the treatment of pulmonary oxygen toxicity, adult respiratory distress syndrome (ARDS), and, potentially, cases of human immunodeficiency virus (HIV-I) infections. This diversity of pharmacological applications of NAC is because of the multifaceted chemical properties of the cysteinyl thiol of the molecule. These include its nucleophilicity and redox activity, providing scavenger and antioxidant properties and its ability to undergo transhydrogenation or thiol-disulfide exchange (TDE) reactions with other thiol redox couples. Advances in the clinical use of NAC have stemmed mainly from the development of suitable analytical techniques for the analysis of NAC and potential metabolites in biological systems. These techniques are being used to determine the human pharmacokinetic behavior of NAC and its metabolic disposition. This chapter describes the analytical concepts that are currently available for the determination of NAC and metabolites in biological fluids. It also presents the available data on the disposition of NAC in humans and discusses the biological properties of NAC. It then discusses some future possibilities of NAC in clinical practice.

References (46)

  • T. Toyoóka et al.

    J. Chromatogr.

    (1983)
  • P.A. Lewis et al.

    J. Chromatogr.

    (1985)
  • I.A. Cotgreave et al.

    Biochem. Biophys. Methods

    (1986)
  • H. Thor et al.

    Arch. Biochem. Biophys.

    (1979)
  • K. Sjödin et al.

    Biochem. Pharmacol.

    (1989)
  • I.A. Cotgreave et al.

    Biochem. Pharmacol.

    (1991)
  • O.I. Aruoma et al.

    Free Radical Biol. Med.

    (1989)
  • I.A. Cotgreave et al.

    Biochem. Pharmacol.

    (1987)
  • C.F. Cesarone et al.

    Mutat. Res.

    (1990)
  • S. De Flora et al.

    Cancer Lett.

    (1986)
  • M. Wilpart et al.

    Cancer Lett.

    (1986)
  • B. Kågedahl et al.

    J. Chromatogr.

    (1982)
  • T. Toyoóka et al.

    Anal. Chem.

    (1984)
  • I.A. Cotgreave et al.

    Biopharm. Drug Dispos.

    (1987)
  • B. Gabard et al.

    Biopharm. Drug Dispos.

    (1991)
  • P. Moldéus et al.

    Respiration

    (1986)
  • I.A. Cotgreave et al.

    Bull. Ear. Physiopathol. Respir.

    (1986)
  • L. Borgström et al.

    Eur. J. Clin. Pharmacol.

    (1986)
  • B. Olsson et al.

    Eur. J. Clin. Pharmacol.

    (1986)
  • I.A. Cotgreave et al.

    Eur. J. Respir. Dis.

    (1987)
  • M.De Bernardi di Valserra et al.

    Eur. J. Clin. Pharmacol.

    (1989)
  • L. De Carro et al.

    Arzneim. Forsch.

    (1989)
  • L. Borgström et al.

    Biopharm. Drug Dispos.

    (1990)
  • Cited by (130)

    • Hormesis determines lifespan

      2024, Ageing Research Reviews
    • Ex vivo treatment with inhaled N-acetylcysteine in porcine lung transplantation

      2017, Journal of Surgical Research
      Citation Excerpt :

      Both in vitro and in vivo studies suggest that NAC enhances intracellular GSH synthesis.27 NAC, which is a precursor of GSH, has been widely used to treat different conditions in clinical practice, such as chronic lung diseases, paracetamol intoxication, pulmonary oxygen toxicity, pulmonary fibrosis, radiocontrast-induced renal toxicity, and human immunodeficiency virus infections.28-30 Furthermore, it has been shown to be beneficial against IRI in many organs including heart and lung.25,26

    View all citing articles on Scopus
    View full text